Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P676: Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United StatesECCO '17 Barcelona
Year: 2017
Authors:

Sandborn W.*1, Sakuraba A.2, Wang A.3, Macaulay D.4, Schemerold L.4, Yang M.5, Skup M.3

1University of California San Diego, La Jolla, United States 2University of Chicago, Chicago, United States 3AbbVie Inc., North Chicago, United States 4Analysis Group, Inc., New York, United States 5Analysis Group, Inc., Boston, United States

P677: Impact of patient reported outcomes, coping strategies and psychosocial factors on medication adherence in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Chao C.-Y.*1,2, Lemieux C.1, Afif W.1, Bitton A.1, Wild G.1, Bessissow T.1

1McGill University Health Centre, Department of Gastroenterology, Montréal, Canada 2Princess Alexandra Hospital, Department of Gastroenterology, Brisbane, Australia

P678: Did toxicity profile of azathioprine changed within the last 10 years: comparative 17 years data from a single tertiary IBD centerECCO '17 Barcelona
Year: 2017
Authors:

Bozcan S., Hatemi I., Yıldırım S., Demir N., Erzin Y., Celik A.F.

Istanbul University Cerrahpasa School of Medicine, Gastroenterology, Istanbul, Turkey

P679: Infliximab biosimilar CT-P13 in inflammatory bowel disease patients that require intensification treatmentECCO '17 Barcelona
Year: 2017
Authors:

Gompertz M., Alfaro I., Ricart E., Lόpez A., Panés J., Gallego M., Barastegui R., Giner A., Vara A., Masamunt M., Ordás I.

Hospital Clinic Barcelona, Department of Gastroenterology, Barcelona, Spain

P680: Quality of sex life in patients with inflammatory bowel disease: the gastroenterologists' perspectiveECCO '17 Barcelona
Year: 2017
Authors:

Rivière P., Laharie D., Zerbib F., Poullenot F.

Bordeaux University Hospital, Bordeaux, France

P681: Assessing internet based information used to aid patient decision making in surgery for perianal Crohn's fistulaECCO '17 Barcelona
Year: 2017
Authors:

Marshall J.*1, Baker D.1, Lee M.2, Jones G.3, Lobo A.4, Brown S.2

1University of Sheffield, The Medical School, Sheffield, United Kingdom 2Sheffield Teaching Hospitals, Colorectal Surgery, Sheffield, United Kingdom 3Leeds Beckett University, School of Social Sciences, Leeds, United Kingdom 4Royal Hallamshire Hospital/University of Sheffield, Department of Gastroenterology, Sheffield, United Kingdom

P682: Risk factors and clinical outcome in IBD patients with melanomaECCO '17 Barcelona
Year: 2017
Authors:

Nissen L.H.*1, Pierik M.2, Derikx L.A.A.P.3, de Jong E.4, Kievit W.3, van den Heuvel T.2, van Rosendael A.5, Plasmeijer E.5, Dewint P.6, Nagtegaal I.D.7, Hoentjen F.3, van der Meulen A.5

1Radboud UMC, Gastroenterology & Hepatology, Nijmegen, Netherlands 2Maastricht University Medical Center, Department of Gastroenterology and Hepatology, Maastricht, Netherlands 3Radboud University Medical Center, Department of Gastroenterology and Hepatology, Nijmegen, Netherlands 4Radboud University Nijmegen Medical Centre, Dermatology, Nijmegen, Netherlands 5Leiden University Medical Center, Department of Gastroenterology and Hepatology, Leiden, Netherlands 6Maasstad Ziekenhuis, Department of Gastroenterology and Hepatology, Rotterdam, Netherlands 7Radboud University Medical Center, Department of Histopathology, Nijmegen, Netherlands

P683: Leishmania infantum asymptomatic infection in inflammatory bowel disease patients under anti-TNF-α treatmentECCO '17 Barcelona
Year: 2017
Authors:

Borruel N.*1, Guillen M.C.2, Salvador F.3, Herrera C.1, Alcover M.M.2, Sulleiro E.4, Robles V.1, Berenguer D.2, Sánchez-Montalvá A.3, Rodríguez V.1, Tomás-Pérez M.2, Molina I.3, Navarro E.1, Iniesta L.2, Fisa R.2, Riera C.2, Casellas F.1

1Hospital Vall d'Hebron, Crohn's and Colitis attention Unit, Barcelona, Spain 2Universitat de Barcelona. Faculty of Pharmacy and Food Science, Department of Biology, Health and Environement. Laboratory of Parasitology, Barcelona, Spain 3Hospital Vall d'Hebron, Department of Infectious Diseases, Barcelona, Spain 4Hospital Vall d'Hebron, Department of Microbiology, Barcelona, Spain

P684: A first clinical trial of a novel narrow spectrum kinase inhibitor TOP1288 in patients with ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Taylor M.*1, Duggal A.1, Rowley A.1, Foster M.1, Sirohi S.1, Solanke Y.1, Walshe C.1, Webber S.1, Travis S.2, Irving P.3

1Topivert Pharma Ltd, London, United Kingdom 2Oxford University Hospitals Trust, Translational Gastroenterology Unit, Oxford, United Kingdom 3Guy's and St Thomas' NHS Foundation Trust, Department of Gastroenterology, London, United Kingdom

P685: Switching from originator-infliximab to biosimilar-infliximab has no influence on health-related quality of life and clinical disease activity among patients with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Huoponen S.*1, Eberl A.1,2, Räsänen P.1,2, Roine R.P.2,3, Sipponen T.1,2, Arkkila P.1,2, Blom M.1

1University of Helsinki, Helsinki, Finland 2Helsinki University Hospital, Helsinki, Finland 3University of Eastern Finland, Kuopio, Finland

P686: Application of dried blood spots for pharmacokinetic profiling of golimumab-treated patients with ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Detrez I.*1, Ballet V.2, Van Assche G.2, Vermeire S.2, Ferrante M.2, Gils A.1

1KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium 2UZ Leuven, Department of Clinical and Experimental Medicine, Leuven, Belgium

P687: Fate of the rectum in anorectal Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Zambonin D., Scaringi S., Di Bella A., Giudici F., Bechi P.

University of Florence, Florence, Italy

P688: Crohn's disease patients with a concordant family history are diagnosed earlier and are at increased risk for complicated diseaseECCO '17 Barcelona
Year: 2017
Authors:

Borren N.*1,2, Conway G.1, Garber J.1,3, Khalili H.1,3, Yajnik V.1,3, Xavier R.1,3, Ananthakrishnan A.1,3

1Massachusetts General Hospital, Department of Gastroenterology, Boston, United States 2University of Groningen, Groningen, Netherlands 3Harvard Medical School, Boston, United States

P689: Biologics utilization in children with inflammatory bowel diseases is higher and earlier than in adults: a report from the epi-IIRN groupECCO '17 Barcelona
Year: 2017
Authors:

Friedman M.*1, Axelrod R.1,2, Rosenblum J.3, Zigman N.3, Goren I.3, Lederman N.4, Cohen N.4, Matz E.5, Dushnitzky D.5, Borovsky N.5, Gavish M.2, Focht G.1, Avitzour M.1, Dotan I.6, Benchimol E.7, Turner D.1

1Shaare Zedek Medical Center, The Juliet Keiden Institute of Pediatric Gastroenterology and Nutrition, Jerusalem, Israel 2The Hebrew University of Jerusalem, School of Computer Science and Engineering, Jerusalem, Israel 3Maccabi Healthcare Services, Tel Aviv, Israel 4Meuhedet Health Services, Tel Aviv, Israel 5Leumit Health Services, Tel Aviv, Israel 6Tel-Aviv Sourasky Medical Center, and the Sackler School of Medicine, IBD Center, Department of Gastroenterology and Liver diseases, Tel Aviv, Israel 7Children's Hospital of Eastern Ontario, University of Ottawa, CHEO Inflammatory Bowel Disease Centre, Ottawa, Canada

P690: Ambient air quality does not affect disease course in inflammatory bowel disease – a population based risk factor analysis using geographic information systemsECCO '17 Barcelona
Year: 2017
Authors:

van den Heuvel T.*1, Bijnens E.2, Verhaegh B.1,3, Nawrot T.2, Zeegers M.4,5, Masclee A.1,3, Oostenbrug L.6, Romberg-Camps M.6, Jonkers D.1, Pierik M.1

1Maastricht University Medical Centre+, Division of Gastroenterology and Hepatology, Maastricht, Netherlands 2Hasselt University, Centre for Environmental Sciences, Diepenbeek, Belgium 3Maastricht University Medical Centre+, Nutrim - School of Nutrition and Translational Research in Metabolism, Maastricht, Netherlands 4Maastricht University Medical Centre+, Department of Complex Genetics, Maastricht, Netherlands 5Maastricht University Medical Centre+, Caphri - School of Public Health and Primary Care, Maastricht, Netherlands 6Zuyderland Medical Centre, Department of Internal Medicine, Sittard-Geleen-Heerlen, Netherlands

P691: UV exposure and skin type are more important than thiopurine exposure for non-melanoma skin cancer risk in IBDECCO '17 Barcelona
Year: 2017
Authors:

Wu Y.*1, Ghaly S.1, Kerr S.2, Krishnaprasad K.3, Prosser R.4, Jackson B.5, Hanigan K.3, Martins D.3, Mountifield R.4, Whiteman D.6, Bampton P.4, Gearry R.5, Radford-Smith G.3, Lawrance I.C.7,8

1St Vincent's Hospital, Department of Gastroenterology, Sydney, Australia 2Kirby Institute, Sydney, Australia 3QIMR Berghofer Medical Research Insitute, Inflammatory Bowel Disease Research Group, Brisbane, Australia 4Flinders Medical Centre, Department of Gastroenterology, Adelaide, Australia 5Christchurch Hospital, Department of Gastroenteology, Christchurch, New Zealand 6QIMR Berghofer Medical Research Insitute, Cancer Control Group, Brisbane, Australia 7University of Western Australia, School of Medicine and Pharmacology, Perth, Australia 8St John of God Hospital, Centre for inflammatory Bowel Diseases, Perth, Australia

P692: Inflammatory bowel diseases in Faroese-born Danish residents and their offspring. Further evidence of the dominant role of environmental factors in IBD developmentECCO '17 Barcelona
Year: 2017
Authors:

Hammer T.*1,2, Lophaven S.N.1, Rubek Nielsen K.3,4, von Euler-Chelpin M.C.1, Weihe P.2, Munkholm P.5, Burisch J.5, Lynge E.1

1University of Copenhagen, Department of Public Health, Copenhagen, Denmark 2The Department of Occupational Medicine and Public Health, Tόrshavn, Faroe Islands 3Medical Centre, National Hospital of the Faroe Islands, Tόrshavn, Faroe Islands 4Genetic Biobank, Tόrshavn, Faroe Islands 5Department of Gastroenterology, North Zealand Hospital, Copenhagen, Denmark

P693: Patients with inflammatory bowel disease who are on immunosuppressive therapy perform regular gynecologic screening for uterine cervical cancer?ECCO '17 Barcelona
Year: 2017
Authors:

Vázquez-Morόn J.M., Cabello Fernández A., Pallarés-Manrique H., Ramos-Lora M.

Hospital General Juan Ramόn Jiménez, Gastroenterology Unit, Huelva, Spain

P694: Disease course during the first five years following diagnosis in a prospective European population-based inception cohort – the ECCO-EpiCom cohortECCO '17 Barcelona
Year: 2017
Authors:

Burisch J.*1, Halfvarson J.2, Kupcinskas L.3, Hernandez V.4, Kaimakliotis I.5, Valpiani D.6, Pedersen N.7, Duricova D.8, Kievit L.9, Dahlerup J.F.10, Fumery M.11, Salupere R.12, Arebi N.13, Nielsen K.R.14, Giannotta M.15, Oksanen P.16, Katsanos K.H.17, Vegh Z.18, Ellul P.19, Schwartz D.20, Čuković-Čavka S.21, D'Incà R.22, Turcan S.23, Magro F.24,25,26, Goldis A.27, Langholz E.28, Lakatos P.L.18, Munkholm P.1 EpiCom Study Group

1North Zealand University Hospital, Department of Gastroenterology, Frederikssund, Denmark 2Faculty of Medicine and Health, Örebro University, Department of Gastronterology, Örebro, Sweden 3Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania 4Complexo Hospitalario Universitario de Vigo, Gastroenterology Department, Vigo, Spain 5Nicosia Private practice, Nicosia Private Practice, Nicosia, Cyprus 6Department of Gastroenterology and Digestive Endoscopy, Morgagni Hospital, Forli, Italy 7Slagelse Hospital, Department of Gastroenterology, Slagelse, Denmark 8Charles University, IBD Center ISCARE, Prague, Czech Republic 9Herning Central Hospital, Department of Medicine, Herning, Denmark 10Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark 11Amiens University and Hospital, Epimad Registry, Gastroenterology Unit, Amiens, France 12Tartu University Hospital, Division of Endocrinology and Gastroenterology, Tartu, Estonia 13St Mark's Hospital, Gastroenterology, London, United Kingdom 14The National Hospital of the Faroe Islands, Medical Department, Tόrshavn, Faroe Islands 15AOU Careggi Regional Referral Center for Inflammatory Bowel Disease, Gastroenterology Department, Florence, Italy 16Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland 17University Hospital, Ioannina, 1st Division of Internal Medicine and Hepato-Gastroenterology Unit, Ioannina, Greece 18Semmelweis University, 1st Department of Medicine, Budapest, Hungary 19Mater Dei Hospital, Division of Gastroenterology, L-Imsida, Malta 20Soroka Medical Center and Ben Gurion University of the Negev, Department of Gastroenterology and Hepatology, Beer Sheva, Israel 21University Hospital Center Zagreb, University of Zagreb School of Medicine, Division of Gastroenterology and Hepatology, Zagreb, Croatia 22Azienda Ospedaliera di Padova, Department of Surgery, Oncology and Gastroenterology, Padova, Italy 23State University of Medicine and Pharmacy of the Republic of Moldova, Department of Gastroenterology, Chisinau, Moldova, Republic of 24University of Porto, Institute for Molecular and Cell Biology, Porto, Portugal 25Hospital de São João, Department of Gastroenterology, Porto, Portugal 26Oporto Medical School, Institute of Pharmacology and Therapeutics, Porto, Portugal 27University of Medicine “Victor Babes”, Clinic of Gastroenterology, Timisoara, Romania 28Gentofte Hospital, Department of Medical Gastroenterology, Copenhagen, Denmark

P695: The risk of proximal disease extension in patients with limited ulcerative colitis in a prospective European population-based inception cohort – the ECCO-EpiCom cohortECCO '17 Barcelona
Year: 2017
Authors:

Burisch J.*1, Halfvarson J.2, Kupcinskas L.3, Hernandez V.4, Kaimakliotis I.5, Valpiani D.6, Pedersen N.7, Duricova D.8, Kievit L.9, Dahlerup J.F.10, Fumery M.11, Salupere R.12, Arebi N.13, Nielsen K.R.14, Giannotta M.15, Oksanen P.16, Katsanos K.H.17, Vegh Z.18, Ellul P.19, Schwartz D.20, Čuković-Čavka S.21, D'Incà R.22, Turcan S.23, Magro F.24,25,26, Goldis A.27, Langholz E.28, Lakatos P.L.18, Munkholm P.1 EpiCom Study Group

1North Zealand University Hospital, Department of Gastroenterology, Frederikssund, Denmark 2Faculty of Medicine and Health, Örebro University, Department of Gastronterology, Örebro, Sweden 3Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania 4Complexo Hospitalario Universitario de Vigo, Gastroenterology Department, Vigo, Spain 5Nicosia Private practice, Nicosia Private practice, Nicosia, Cyprus 6Department of Gastroenterology and Digestive Endoscopy, Morgagni Hospital, Forli, Italy 7Slagelse Hospital, Department of Gastroenterology, Slagelse, Denmark 8Charles University, IBD Center ISCARE, Prague, Czech Republic 9Herning Central Hospital, Department of medicine, Herning, Denmark 10Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark 11Amiens University and Hospital, Epimad Registry, Gastroenterology Unit, Amiens, France 12Tartu University Hospital, Division of Endocrinology and Gastroenterology, Tartu, Estonia 13St Mark's Hospital, Gastroenterology, London, United Kingdom 14The National Hospital of the Faroe Islands, Medical department, Tόrshavn, Faroe Islands 15AOU Careggi Regional Referral Center for Inflammatory Bowel Disease, Gastroenterology Department, Florence, Italy 16Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland 17University Hospital, Ioannina, 1st Division of Internal Medicine and Hepato-Gastroenterology Unit, Ioannina, Greece 18Semmelweis University, 1st Department of Medicine, Budapest, Hungary 19Mater Dei Hospital, Division of Gastroenterology, L-Imsida, Malta 20Soroka Medical Center and Ben Gurion University of the Negev, Department of Gastroenterology and Hepatology, Beer Sheva, Israel 21University Hospital Center Zagreb, University of Zagreb School of Medicine, Division of Gastroenterology and Hepatology, Zagreb, Croatia 22Azienda Ospedaliera di Padova, Department of Surgery, Oncology and Gastroenterology, Padova, Italy 23State University of Medicine and Pharmacy of the Republic of Moldova, Department of Gastroenterology, Chisinau, Moldova, Republic of 24University of Porto, Institute for molecular and cell biology, Porto, Portugal 25Hospital de São João, Department of Gastroenterology, Porto, Portugal 26Oporto Medical School, Institute of Pharmacology and Therapeutics, Porto, Portugal 27University of Medicine “Victor Babes”, Clinic of Gastroenterology, Timisoara, Romania 28Gentofte Hospital, Department of Medical Gastroenterology, Copenhagen, Denmark